990 results on '"Czarnecka, Danuta"'
Search Results
52. Factors determining acceptance of illness in patients with arterial hypertension and comorbidities
53. EFFECTS OF URIC ACID LOWERING THERAPY IN PATIENTS WITH PRIMARY HYPERTENSION
54. SEX, METABOLIC AND PHARMACOLOGICAL MODULATORS OF SODIUM HANDLING IN POPULATION WITH PREVAILING SODIUM INTAKE
55. OUTCOME-DRIVEN THRESHOLDS OF CENTRAL SYSTOLIC BLOOD PRESSURE AND CROSS-CLASSIFICATION OF SYSTOLIC HYPERTENSION AT CENTRAL AND BRACHIAL ARTERIES
56. ASSOCIATION OF CARDIOVASCULAR ENDPOINTS AND MORTALITY WITH CENTRAL AND PERIPHERAL PULSATILE BLOOD PRESSURE COMPONENTS
57. THE PREVALENCE OF DRUG-RELATED ADVERSE REACTIONS AMONG HYPERTENSIVE PATIENTS
58. The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina
59. A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland
60. Universal Algorithm for Diagnosis of Biventricular Capture in Patients with Cardiac Resynchronization Therapy
61. Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease
62. Obesity in patients with established coronary artery disease over a 20-year period (1997–2017)
63. Plasma renin activity, serum aldosterone concentration and selected organ damage indices in essential arterial hypertension
64. Ocena i kontrola czynników ryzyka chorób sercowo-naczyniowych w profilaktyce pierwotnej
65. Nowoczesna terapia nadciśnienia tętniczego w codziennej praktyce
66. 30-letnia kobieta z nadciśnieniem tętniczym w I trymestrze ciąży
67. Podstawowe klasy leków stosowanych w terapii nadciśnienia tętniczego
68. Algorytmy farmakoterapii nadciśnienia tętniczego w świetle aktualnych wytycznych
69. Wpływ terapii resynchronizującej serca na wrażliwość odruchu z baroreceptorów tętniczych oraz nasilenie objawów depresji u chorych z przewlekłą niewydolnością serca
70. Dekompensacja układu krążenia i płyn w worku osierdziowym o niewyjaśnionej etiologii
71. Migotanie przedsionków - kiedy rozpocząć diagnostykę i u kogo wdrożyć leczenie
72. Nadciśnienie tętnicze w ciąży - zasady farmakoterapii
73. Rozpoczynanie leczenia nadciśnienia tętniczego, cele leczenia i docelowe wartości ciśnienia
74. CHADS2 and CHA2DS2-VASc scores predict long-term mortality in patients with typical atrial flutter after catheter ablation
75. P5.21 Percutaneous Coronary Interventions of Chronic Total Occlusions: Gender Differences – Single Center Experience
76. P7.4 Morning Central Blood Pressure Surge Does Not Differ Between Men and Women
77. P4.10 Association of Arterial Stiffness with Blood Pressure Variability
78. The relation of nocturnal exposure to aircraft noise and aircraft noise-induced insomnia with blood pressure
79. Pharmacotherapy in patients with chronic coronary syndromes over a 20-year period (1997–2017)
80. Mortality and morbidity in cardiac resynchronization patients: impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome
81. Electrocardiographic Patterns during Left Ventricular Epicardial Pacing
82. Electrocardiographic Diagnosis of Biventricular Pacing in Patients with Nonapical Right Ventricular Leads
83. Secondary prevention of coronary heart disease in Poland: does sex matter? Results from the POLASPIRE survey.
84. Ascending aortic blood pressure-derived indices are not correlated with the extent of coronary artery disease in patients with impaired left ventricular function
85. Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias
86. Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure
87. Left ventricular lead implantation at a phrenic stimulation site is safe and effective
88. Mortality in patients after acute myocardial infarction managed by cardiologists and primary care physicians: a systematic review
89. Increased preexcitation on electrocardiography improves accuracy of algorithms for accessory pathway localization in Wolff–Parkinson–White syndrome
90. Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey
91. Influence of energy drinks on acute hemodynamic parameters in young healthy adults: a randomized double-blind placebo-controlled crossover pilot study
92. Malignant ventricular arrhythmias and other complications of untreated accessory pathways: an analysis of prevalence and risk factors in over 600 ablation cases
93. CHADS2 and CHA2DS2-VASc scores as tools for long-term mortality prognosis in patients with typical atrial flutter after catheter ablation
94. Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus – Polish multicenter study POLASPIRE
95. Programmed deep septal stimulation: A novel maneuver for the diagnosis of left bundle branch capture during permanent pacing
96. Temporal changes in the secondary prevention of coronary artery disease in patients following myocardial revascularization
97. P34 24-Hour Ambulatory Brachial Versus Aortic Systolic Blood Pressure: Relationship with Left Ventricular Mass Significantly Differs. Pooled Results from the International 24 Hour Aortic Blood Pressure Consortium (i24ABC)
98. Diagnostic value of implantable loop recorder in patients undergoing cryoballoon ablation of atrial fibrillation
99. Predicting future cardiovascular risk from blood pressure response to dynamic exercise: a neglected risk factor?
100. Rate‐related block during permanent His bundle pacing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.